Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Curr Opin Biotechnol. 2018 Mar 26;52:74–79. doi: 10.1016/j.copbio.2018.02.016

Table 1.

Applications of VLRs in Biomedical Research

Application VLR function Result References
Therapeutic targeting Inhibit signaling pathway IL6 binder Inhibits IL-6 induced signaling pathway in non-small cell lung cancer cells [29]
Inhibit signaling pathway C5a binder Inhibits C5a pathway to suppress proinflammatory response [27]
Inhibit signaling pathway VEGF binder Blocks the VEGF signaling pathway for age-related macular degeneration [33]
Drug delivery CAR-VLR B-cells and CD5 binder Expresses on effector cells, redirect to target cells, and activates cytotoxicity [34]
VLR-drug conjugate EGFR binder Chemoenzymatically attaches drug for tumor suppression [35]
Nanoparticle EGFR binder Self-assembled nanoparticles target tumors [36]
Diagnostics/Imaging Biomarker discovery CD38 binder Novel epitope that exclusively binds PCs [30]
Diagnostics TF-α binder Stains tumor tissue with worse survival rate [20]
Diagnostics Anti-idiotype binder Used to monitor lymphocytic leukemia [37]
Molecular imaging EGFR binder In vivo tumor imaging [38,39]
Molecular imaging mCherry binder Tracks protein-protein interaction in real time [40]
Plant research HopM1 binder Expresses and binds in some plant environments [28]
Other Stabilization Consensus sequence Able to crystalize LRRTM2 by altering convex surface based on VLR sequence [41]
Stabilization Stable caps Resolves crystal structure of LRR proteins using caps comprised of VLR sequence [42,43]
Vaccine carrier Multimerizing tail Creates multimer with hidden VLR sequence resulting in high vaccine Ab titers [44]